News and Publications2022-09-10T02:30:43-07:00

News and Events

Recent News and Publications



October 20, 2020

Novel Dual MTOR Inhibitor/AMPK Activator Mitigates Doxorubicin Cardiotoxicity And Potentiates Its Chemotherapeutic Efficacy Against Triple Negative Breast Cancer”, Scientific Sessions 2020

April 26, 2020

Synergistic anti-metastatic effect of pembrolizumab in combination with a novel mTORC1 inhibitor/AMPK agonist in a CAM metastatic triple negative breast cancer model,  Virtual AACR 2020 Annual Meeting

August 2019

“Novel Dual MTOR Inhibitors/AMPK Activators Attenuate Doxorubicin-induced Cardiotoxicity” Rapid Fire Oral Presentation in American Heart Association Scientific Sessions

August 2018

A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure, American Journal of Physiology Heart and Circulatory Physiology


Go to Top